神州细胞
(688520)
| 流通市值：209.71亿 | | | 总市值：209.71亿 |
| 流通股本：4.45亿 | | | 总股本：4.45亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,311,881,128.84 | 972,020,482.48 | 519,736,501.03 | 2,512,708,141.32 |
| 营业收入 | 1,311,881,128.84 | 972,020,482.48 | 519,736,501.03 | 2,512,708,141.32 |
| 二、营业总成本 | 1,491,402,986.03 | 987,045,730.66 | 488,981,324.11 | 2,015,810,647 |
| 营业成本 | 77,530,046.99 | 50,672,182.64 | 26,631,243.4 | 102,702,162.43 |
| 税金及附加 | 10,387,466.23 | 6,952,661.84 | 3,621,350.13 | 16,223,801.78 |
| 销售费用 | 628,510,651.19 | 421,692,188.2 | 214,581,401.57 | 694,058,784.98 |
| 管理费用 | 124,665,441.74 | 85,399,687.34 | 45,457,796.26 | 190,211,465.55 |
| 研发费用 | 581,824,568.34 | 378,953,532.38 | 177,805,332.61 | 911,193,303.73 |
| 财务费用 | 68,484,811.54 | 43,375,478.26 | 20,884,200.14 | 101,421,128.53 |
| 其中:利息费用 | 65,898,999.41 | 41,951,607.02 | 21,231,815.4 | 103,550,412.74 |
| 其中:利息收入 | 1,407,568.62 | 949,103.75 | 465,840.1 | 3,884,472.35 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 14,081,917.44 | 14,590,195.22 | 19,561.64 | - |
| 加:投资收益 | 734,251.04 | 366,004.48 | 286,033.41 | 1,264,588.45 |
| 资产处置收益 | - | - | - | 3,194.48 |
| 资产减值损失(新) | -11,836,997.31 | -11,524,437.59 | -2,813,078.62 | -8,385,884.89 |
| 信用减值损失(新) | -6,268,772.81 | -6,622,082.22 | -3,489,427.4 | -2,089,233.81 |
| 其他收益 | 16,721,120.17 | 11,670,658.06 | 7,420,700.69 | 80,715,352.45 |
| 四、营业利润 | -166,090,338.66 | -6,544,910.23 | 32,178,966.64 | 568,405,511 |
| 加:营业外收入 | 100,036,158.09 | 100,027,150.44 | 100,011,283.53 | 436,919 |
| 减:营业外支出 | 185,225,421.1 | 127,340,391.5 | 68,250,520.55 | 456,493,473.95 |
| 五、利润总额 | -251,279,601.67 | -33,858,151.29 | 63,939,729.62 | 112,348,956.05 |
| 六、净利润 | -251,279,601.67 | -33,858,151.29 | 63,939,729.62 | 112,348,956.05 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -251,279,601.67 | -33,858,151.29 | 63,939,729.62 | 112,348,956.05 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -250,672,332.75 | -33,771,096.29 | 63,767,813.04 | 111,951,088.88 |
| 少数股东损益 | -607,268.92 | -87,055 | 171,916.58 | 397,867.17 |
| 扣除非经常损益后的净利润 | -200,303,428.99 | -36,108,173.65 | 23,577,445.5 | 474,410,588.61 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.6 | -0.1 | 0.13 | 0.24 |
| (二)稀释每股收益 | -0.6 | -0.1 | 0.13 | 0.24 |
| 八、其他综合收益 | 92,768.44 | 268,031.28 | 120,430.16 | -422,730.65 |
| 归属于母公司股东的其他综合收益 | 92,536.52 | 267,361.2 | 120,129.08 | -421,673.83 |
| 九、综合收益总额 | -251,186,833.23 | -33,590,120.01 | 64,060,159.78 | 111,926,225.4 |
| 归属于母公司股东的综合收益总额 | -250,579,796.23 | -33,503,735.09 | 63,887,942.12 | 111,529,415.05 |
| 归属于少数股东的综合收益总额 | -607,037 | -86,384.92 | 172,217.66 | 396,810.35 |
| 公告日期 | 2025-10-31 | 2025-08-29 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |